Erbez Georgia — SEC insider filings

SEC reporting owner CIK 1557930. 17 insider filings on record with FilingPulse; latest filed 2026-10-14.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2020-08-20 to 2026-10-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Harpoon Therapeutics, Inc. (HARP)Chief Financial Officer63 legs · 17,398 sh · $164,767—5
CODEXIS, INC. (CDXS)See Remarks6—3 legs · 16,400 sh · $29,2495
Coherus Oncology, Inc. (CHRS)Director3——3
Sierra Oncology, Inc. (SRRA)Director2——2

Insider filings — Erbez Georgia

FiledFormIssuerReported transactionsSource
2026-10-144CODEXIS, INC. (CDXS)Sale (S): 6,335 @ $1.36EDGAR
2026-02-254CODEXIS, INC. (CDXS)Grant/award (A): 316,100 (derivative) @ $0EDGAR
2026-02-094CODEXIS, INC. (CDXS)Sale (S): 3,826 @ $1.31EDGAR
2025-10-154CODEXIS, INC. (CDXS)Sale (S): 6,239 @ $2.50EDGAR
2025-06-134Coherus Oncology, Inc. (CHRS)Grant/award (A): 112,000 (derivative) @ $0EDGAR
2025-02-074CODEXIS, INC. (CDXS)Grant/award (A): 26,875 @ $0 · Grant/award (A): 161,250 (derivative) @ $0EDGAR
2024-10-104CODEXIS, INC. (CDXS)Grant/award (A): 50,000 @ $0 · Grant/award (A): 300,000 (derivative) @ $0EDGAR
2024-06-054Coherus BioSciences, Inc. (CHRS)Grant/award (A): 114,000 (derivative) @ $0EDGAR
2024-02-224Coherus BioSciences, Inc. (CHRS)Grant/award (A): 54,000 (derivative) @ $0EDGAR
2022-07-014Sierra Oncology, Inc. (SRRA)Disposition to issuer (D): 18,000 (derivative) @ $0EDGAR
2022-02-014Harpoon Therapeutics, Inc. (HARP)Grant/award (A): 115,000 (derivative) @ $0EDGAR
2021-11-154Harpoon Therapeutics, Inc. (HARP)Grant/award (A): 115,000 (derivative) @ $0EDGAR
2021-09-224Harpoon Therapeutics, Inc. (HARP)Purchase (P): 10,300 @ $8.10EDGAR
2021-06-044Sierra Oncology, Inc. (SRRA)Grant/award (A): 18,000 (derivative) @ $0EDGAR
2021-02-184Harpoon Therapeutics, Inc. (HARP)Option exercise (M): 25,000 @ $2.12 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2021-01-294Harpoon Therapeutics, Inc. (HARP)Grant/award (A): 72,000 (derivative) @ $0EDGAR
2020-08-204Harpoon Therapeutics, Inc. (HARP)Purchase (P): 2,098 @ $11.60 · Purchase (P): 5,000 @ $11.40EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1557930 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs